164. 眼皮膚白皮症 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 16 / 薬物数 : 44 - (DrugBank : 27) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 137

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
6-mercaptopurine
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
Abatacept
   Emory University
      2014   Phase 1   NCT01917708   United States
Adalimumab
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
Alefacept
   Emory University
      2010   -   NCT01319851   United States
Alemtuzumab 0.2 MG
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Alemtuzumab 0.3 MG
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Allogeneic bone marrow transplantation
   Fairview University Medical Center
      2000   -   NCT00006054   United States
Allogeneic hematopoietic stem cell transplantation
   Fairview University Medical Center
      2000   -   NCT00006056   United States
ANTI-thymocyte globulin
   Fairview University Medical Center
      2000   -   NCT00006056   United States
      2000   -   NCT00006054   United States
   Masonic Cancer Center, University of Minnesota
      2002   Phase 2   NCT00176865   United States
Blood parameters
   Assistance Publique - Hôpitaux de Paris
      2024   -   NCT06138509   France
Busulfan
   Fairview University Medical Center
      2000   -   NCT00006056   United States
      2000   -   NCT00006054   United States
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Campath 1H
   Masonic Cancer Center, University of Minnesota
      2002   Phase 2   NCT00176865   United States
Corticosteroids
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
Cyclophosphamide
   Fairview University Medical Center
      2000   -   NCT00006056   United States
      2000   -   NCT00006054   United States
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Cyclosporin A
   Masonic Cancer Center, University of Minnesota
      2002   Phase 2   NCT00176865   United States
Cyclosporine
   Fairview University Medical Center
      2000   -   NCT00006056   United States
      2000   -   NCT00006054   United States
Dosage OF serotonin and metabolites
   Assistance Publique - Hôpitaux de Paris
      2024   -   NCT06138509   France
Erythromycin
   National Human Genome Research Institute (NHGRI)
      2007   Phase 1/Phase 2   NCT00467831   United States
Etoposide
   Fairview University Medical Center
      2000   -   NCT00006056   United States
      2000   -   NCT00006054   United States
Filgrastim
   Fairview University Medical Center
      2000   -   NCT00006056   United States
Fludarabine
   Masonic Cancer Center, University of Minnesota
      2002   Phase 2   NCT00176865   United States
Fludarabine phosphate 30 MG
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Fludarabine phosphate 40 MG
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Infliximab
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
Levodopa/carbidopa
   University of Wisconsin, Madison
      2012   Phase 2   NCT01663935   United States
Losartan
   National Human Genome Research Institute (NHGRI)
      2007   Phase 1/Phase 2   NCT00467831   United States
Lutein plus zeaxanthin
   Johns Hopkins University
      2014   -   NCT02200263   United States
Melphalan
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
      2002   Phase 2   NCT00176865   United States
Mesalamine
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
Mesna
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Methotrexate
   Fairview University Medical Center
      2000   -   NCT00006056   United States
      2000   -   NCT00006054   United States
Methylprednisolone
   Fairview University Medical Center
      2000   -   NCT00006054   United States
Mycophenolate mofetil
   Masonic Cancer Center, University of Minnesota
      2002   Phase 2   NCT00176865   United States
Myeloablative conditioning regimen
   Masonic Cancer Center, University of Minnesota
      2000   Phase 2/Phase 3   NCT00176826   United States
N-acetylcysteine
   National Human Genome Research Institute (NHGRI)
      2007   Phase 1/Phase 2   NCT00467831   United States
Nitisinone
   National Eye Institute (NEI)
      2013   Phase 1/Phase 2   NCT01838655   United States
Pirfenidone
   Jesse Roman
      2019   Phase 2   NCT04193592   Puerto Rico;United States
   William Gahl, M.D.
      2005   Phase 2   NCT00001596   Puerto Rico;United States
Pravastatin
   National Human Genome Research Institute (NHGRI)
      2007   Phase 1/Phase 2   NCT00467831   United States
Prednisone
   Fairview University Medical Center
      2000   -   NCT00006054   United States
Stem cell transplant
   Masonic Cancer Center, University of Minnesota
      2002   Phase 2   NCT00176865   United States
      2000   Phase 2/Phase 3   NCT00176826   United States
Stem cell transplantation
   Masonic Cancer Center, University of Minnesota
      2012   -   NCT01652092   United States
Tacrolimus
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00514982   United States
Transplant preparative regimen OF alemtuzumab, fludarabine, thiotepa, and melphalan
   Washington University School of Medicine
      2013   Phase 2   NCT01821781   United States
Zileuton
   National Human Genome Research Institute (NHGRI)
      2007   Phase 1/Phase 2   NCT00467831   United States